736 related articles for article (PubMed ID: 21963997)
21. Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1.
Yu L; Tu Y; Jia X; Fang K; Liu L; Wan L; Xiang C; Wang Y; Sun X; Liu T; Yu D; Cao W; Song Y; Fan Y
Cell Physiol Biochem; 2017; 42(1):55-67. PubMed ID: 28494457
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
[TBL] [Abstract][Full Text] [Related]
23. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
Lang M; Kojonazarov B; Tian X; Kalymbetov A; Weissmann N; Grimminger F; Kretschmer A; Stasch JP; Seeger W; Ghofrani HA; Schermuly RT
PLoS One; 2012; 7(8):e43433. PubMed ID: 22912874
[TBL] [Abstract][Full Text] [Related]
24. Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism.
Li J; Zhang P; Zhang QY; Zhang SM; Guo HT; Bi H; Wang YM; Sun X; Liu JC; Cheng L; Cui Q; Yu SQ; Kaye AD; Yi DH; Pei JM
Vascul Pharmacol; 2009; 51(2-3):72-7. PubMed ID: 19351568
[TBL] [Abstract][Full Text] [Related]
25. Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects Against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide Synthase.
Chalupsky K; Kračun D; Kanchev I; Bertram K; Görlach A
Antioxid Redox Signal; 2015 Nov; 23(14):1076-91. PubMed ID: 26414244
[TBL] [Abstract][Full Text] [Related]
26. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
[TBL] [Abstract][Full Text] [Related]
27. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
28. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
[TBL] [Abstract][Full Text] [Related]
29. Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway.
Zhang L; Pu Z; Wang J; Zhang Z; Hu D; Wang J
Int J Mol Sci; 2014 May; 15(5):8153-68. PubMed ID: 24821539
[TBL] [Abstract][Full Text] [Related]
30. Leptin knockout attenuates hypoxia-induced pulmonary arterial hypertension by inhibiting proliferation of pulmonary arterial smooth muscle cells.
Chai S; Wang W; Liu J; Guo H; Zhang Z; Wang C; Wang J
Transl Res; 2015 Dec; 166(6):772-82. PubMed ID: 26470682
[TBL] [Abstract][Full Text] [Related]
31. Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension.
Mouraret N; Marcos E; Abid S; Gary-Bobo G; Saker M; Houssaini A; Dubois-Rande JL; Boyer L; Boczkowski J; Derumeaux G; Amsellem V; Adnot S
Circulation; 2013 Apr; 127(16):1664-76. PubMed ID: 23513067
[TBL] [Abstract][Full Text] [Related]
32. Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation.
Zuckerbraun BS; Shiva S; Ifedigbo E; Mathier MA; Mollen KP; Rao J; Bauer PM; Choi JJ; Curtis E; Choi AM; Gladwin MT
Circulation; 2010 Jan; 121(1):98-109. PubMed ID: 20026772
[TBL] [Abstract][Full Text] [Related]
33. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
[TBL] [Abstract][Full Text] [Related]
35. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
[TBL] [Abstract][Full Text] [Related]
36. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
37. Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways.
Lee MY; Tsai KB; Hsu JH; Shin SJ; Wu JR; Yeh JL
Sci Rep; 2016 Sep; 6():31788. PubMed ID: 27581840
[TBL] [Abstract][Full Text] [Related]
38. Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats.
Zhang D; Wang G; Han D; Zhang Y; Xu J; Lu J; Li S; Xie X; Liu L; Dong L; Li M
Life Sci; 2014 Mar; 98(1):39-43. PubMed ID: 24412385
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of pulmonary arterial smooth muscle cell proliferation following hypoxic pulmonary hypertension by the Na+/H+ exchange inhibitor amiloride.
Liu Y; Zhang B; Dong MQ; Niu W; Luo Y; Gao YQ; Li ZC
Chin J Physiol; 2010 Feb; 53(1):36-44. PubMed ID: 21789883
[TBL] [Abstract][Full Text] [Related]
40. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling.
Dumitrascu R; Weissmann N; Ghofrani HA; Dony E; Beuerlein K; Schmidt H; Stasch JP; Gnoth MJ; Seeger W; Grimminger F; Schermuly RT
Circulation; 2006 Jan; 113(2):286-95. PubMed ID: 16391154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
